Oxurion NV risk profile

79 Stretched several inputs deteriorating together

Measured 1 September 2026 from TG40's filed statements. Recomputed nightly.

79 (Stretched), driven by Leverage and coverage at 100, over 3 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation96AcuteStableDrawdown from the 52-week high — 97.7%
Operating pressureReads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company.
Cash conversionReads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company.
Leverage and coverage100AcuteWorseningNet debt to EBITDA
Competitive position69StretchedStableOperating-margin gap against peers — -358.1 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Oxurion NV